Literature DB >> 3608243

Vinblastine but not other microtubule inhibitors block transferrin endocytosis and iron uptake by reticulocytes.

E H Morgan, B J Iacopetta.   

Abstract

The antimicrotubule reagents, colchicine, griseofulvin, nocodazole, podophylotoxin and taxol had no effect on transferrin endocytosis or iron uptake by rabbit or rat reticulocytes but were inhibitory when used at high concentrations with rat fetal liver erythroid cells. The results imply that microtubules do not have a role in endocytosis and iron uptake by reticulocytes but may have a permissive role in the fetal cells. The only reagent found to inhibit iron uptake by reticulocytes was vinblastine. It was shown to act by inhibiting the endocytosis of transferrin. It is concluded that this effect is not the result of an interaction with microtubules, but may result from a non-specific action on the cell membrane or a more specific effect, such as inhibition of calmodulin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3608243     DOI: 10.1111/j.1440-1681.1987.tb00965.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  4 in total

Review 1.  Roles of iron in neoplasia. Promotion, prevention, and therapy.

Authors:  E D Weinberg
Journal:  Biol Trace Elem Res       Date:  1992-08       Impact factor: 3.738

2.  Multiple GTP-binding proteins participate in clathrin-coated vesicle-mediated endocytosis.

Authors:  L L Carter; T E Redelmeier; L A Woollenweber; S L Schmid
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

3.  Mutations in human dynamin block an intermediate stage in coated vesicle formation.

Authors:  A M van der Bliek; T E Redelmeier; H Damke; E J Tisdale; E M Meyerowitz; S L Schmid
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

Review 4.  Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing.

Authors:  Oleg O Glebov
Journal:  FEBS J       Date:  2020-06-02       Impact factor: 5.622

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.